好看日韩在线视频免费,日本不卡一区二区三区,三级a全过程在线观看,亚洲精品国产9999久久久久

公司提供的4-甲氧基肉桂酸830-09-1售后服務(wù)品質(zhì)保證，貨源充足。嚴(yán)格的質(zhì)量控制體系，包括：優(yōu)級純，分析純，化學(xué)純，試劑級，基準(zhǔn)試劑，實驗純，教學(xué)試劑，高純試劑，色譜純，光譜純，電子純。
4-甲氧基肉桂酸830-09-1售后服務(wù)其他中文名稱： 對甲氧基；對甲氧基肉桂酸；4-甲氧基苯丙烯酸 
英文名稱： 4-Methoxycinnamic acid 
其他英文名稱： p-Methoxycinnamic acid；3-(4-Methoxyphenyl)-2-propenoic acid 
產(chǎn)品規(guī)格： AR，99% 
包 裝： 5克/25克/100克/500克
：830-09-1
C10H10O3=178.19
級別：AR
含量：≥99%
熔點：170～175℃
干燥失重：≤0.5%
性狀：至淡黃色結(jié)晶性粉末，溶于乙醇,乙酸乙酯等有機(jī)溶劑中，不溶于水
用途：生化研究。用在化妝品紫外線吸收劑
保存：RT

特點:
1.現(xiàn)貨直銷，當(dāng)天下單，當(dāng)天發(fā)貨。
2.產(chǎn)品優(yōu)質(zhì)，到貨快，免費快遞。
3.售前、售中、售后服務(wù)好。
有全、新、優(yōu)、品、好五大特點：
全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
品：公司代理sigma,amresco,oxoid,wako,R&D,RB,MBL,TCI,GIBIO,等國內(nèi)外。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
我們提供試劑品牌有Merck、Spectrum、BioAssay Systems、Jaica、Scharlab、Sigma-Aldrich、Amresco、Amersham等試劑品牌，試劑純度高、規(guī)格多、包裝好，規(guī)格包括：優(yōu)級純，分析純，化學(xué)純，試劑級，基準(zhǔn)試劑，實驗純，教學(xué)試劑，高純試劑，色譜純，光譜純，電子純。

Centaurin beta 2    英文名稱：    CENTB2蛋白抗體     0.1ml
CENPQ    英文名稱：    著絲粒蛋白Q抗體     0.1ml
Centaurin alpha 2    英文名稱：    CENTA2蛋白抗體     0.1ml
CENTB1    英文名稱：    胞吞再循環(huán)相關(guān)銜接蛋白CENTB1抗體     0.1ml
phospho-CENTB1 (Ser554)    英文名稱：    磷酸化胞吞再循環(huán)相關(guān)銜接蛋白CENTB1抗體     0.1ml
CENTD1    英文名稱：    CENTD1蛋白抗體     0.1ml
CENTG3    英文名稱：    CENTG3蛋白抗體     0.1ml
Centrin 3    英文名稱：    中心體蛋白3抗體     0.1ml
Centrin-1+Centrin-2    英文名稱：    中心體蛋白1+2抗體     0.1ml
Centrin 2    英文名稱：    中心體蛋白2抗體     0.1ml
CEP120    英文名稱：    中心體蛋白CEP120抗體     0.1ml
CEP164    英文名稱：    中心體蛋白CEP128抗體     0.1ml
CEP170    英文名稱：    中心體蛋白CEP170抗體     0.1ml
CDX4    英文名稱：    尾型同源盒轉(zhuǎn)錄因子4抗體     0.2ml
CUTC    英文名稱：    銅轉(zhuǎn)運蛋白CUTC抗體     0.2ml
CUTL1    英文名稱：    CUTL1蛋白抗體     0.2ml
CTNS    英文名稱：    抗體     0.2ml
CTRB1    英文名稱：    B抗體     0.2ml
CTRP2    英文名稱：    補(bǔ)體C1q壞死因子相關(guān)蛋白2抗體     0.2ml
CSTF3    英文名稱：    細(xì)胞分化促進(jìn)因子77抗體     0.1ml
CSTL1    英文名稱：    半蛋白酶抑制劑樣蛋白1抗體     0.2ml

DOM (25 mg)    2,5-Dimethoxy-4-methylamphetamine|STP, DOM, 2,5-dimethoxy-α,4-dimethyl-benzeneethanamine
D2PM -hydrochloride) (25 mg)    Diphenylprolinol|Diphenyl-2-pyrrolidinemethanol, D2PM -hydrochloride), α,α-diphenyl-2R-pyrrolidinemethanol, monohydrochloride
3,4-Dimethylethcathinone -hydrochloride) (50 mg)    3,4-DMEC, 3,4-Dimethylethcathinone -hydrochloride), 1-(3,4-dimethylphenyl)-2-(ethylamino)propan-1-one, monohydrochloride
Synthetic Cannabinoid HPLC Mixture III (1 ea)    Synthetic Cannabinoid HPLC Mixture III
Synthetic Cannabinoid HPLC Mixture IV (1 ea)    Synthetic Cannabinoid HPLC Mixture IV
Synthetic Cannabinoid HPLC Mixture V -AM Series) (1 ea)    Synthetic Cannabinoid HPLC Mixture V -AM Series)
K252b (100 ug)    K252b, (9S,1R,12R)-2,3,9,1,11,12-hexahydro-1-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3’,2’,1’-kl]pyrrolo[3,4-i][1,6]benzodiazocine-1-carboxylic acid
K252b (50 ug)    K252b, (9S,1R,12R)-2,3,9,1,11,12-hexahydro-1-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3’,2’,1’-kl]pyrrolo[3,4-i][1,6]benzodiazocine-1-carboxylic acid
UR-144 (1 mg)    KM-X1, UR-144, (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone
UR-144 (5 mg)    KM-X1, UR-144, (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone
Coenzyme Q10 (1 g)    Ubiquinone-1|CoQ1|NSC 14865|Ubidecarenone, Coenzyme Q10, 2-[(2E,6E,1E,14E,18E,22E,26E,3E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,1,14,18,22,26,3,34,38-tetracontadecaen-1-yl]-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
Coenzyme Q10 (100 mg)    Ubiquinone-1|CoQ1|NSC 14865|Ubidecarenone, Coenzyme Q10, 2-[(2E,6E,1E,14E,18E,22E,26E,3E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,1,14,18,22,26,3,34,38-tetracontadecaen-1-yl]-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
Coenzyme Q10 (200 mg)    Ubiquinone-1|CoQ1|NSC 14865|Ubidecarenone, Coenzyme Q10, 2-[(2E,6E,1E,14E,18E,22E,26E,3E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,1,14,18,22,26,3,34,38-tetracontadecaen-1-yl]-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
STS-135 (1 mg)    N-adamantyl-1-fluoropentylindole-3-Carboxamide, STS-135, 1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide
STS-135 (5 mg)    N-adamantyl-1-fluoropentylindole-3-Carboxamide, STS-135, 1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide
XLR11 (1 mg)    5-fluoro UR-144, XLR11, (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
XLR11 (5 mg)    5-fluoro UR-144, XLR11, (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
AKB48 (1 mg)    APINACA, AKB48, 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide
AKB48 (5 mg)    APINACA, AKB48, 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide
Bexarotene (25 mg)    LG 169|LGD 169|Ro 26-4455|SR 11247|Targretin, Bexarotene, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)-benzoic acid
Amphotericin B (1 g)    Abelcet
Amphotericin B (5 g)    Abelcet
Amphotericin B (500 mg)    Abelcet
JWH 018 N-pentanoic acid metabolite-d5 (10 mg)    JWH 018 N-pentanoic acid metabolite-d5, 5-(3-(1-naphthoyl)-1H-indol-1-yl)-pentanoic-2,4,5,6,7-d5-acid
MAM2201 N--4-hydroxypentyl) metabolite (10 mg)    MAM2201 N--4-hydroxypentyl) metabolite, (1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone
MAM2201 N--4-hydroxypentyl) metabolite (5 mg)    MAM2201 N--4-hydroxypentyl) metabolite, (1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone
Brefeldin A (10 mg)    Ascotoxin|Cyanein|Decumbin|NSC 17456|NSC 24439|NSC 5631|NSC 89671|Nectrolide|Synergisidin|BFA, Brefeldin A, (1R,2E,6S,1E,11aS,13S,14aR)-1,6,7,8,9,11a,12,13,14,14a-decahydro-1,13-dihydroxy-6-methyl-4H-cyclopent[f]oxacyclotridecin-4-one
Brefeldin A (25 mg)    Ascotoxin|Cyanein|Decumbin|NSC 17456|NSC 24439|NSC 5631|NSC 89671|Nectrolide|Synergisidin|BFA, Brefeldin A, (1R,2E,6S,1E,11aS,13S,14aR)-1,6,7,8,9,11a,12,13,14,14a-decahydro-1,13-dihydroxy-6-methyl-4H-cyclopent[f]oxacyclotridecin-4-one
Brefeldin A (5 mg)    Ascotoxin|Cyanein|Decumbin|NSC 17456|NSC 24439|NSC 5631|NSC 89671|Nectrolide|Synergisidin|BFA, Brefeldin A, (1R,2E,6S,1E,11aS,13S,14aR)-1,6,7,8,9,11a,12,13,14,14a-decahydro-1,13-dihydroxy-6-methyl-4H-cyclopent[f]oxacyclotridecin-4-one
19-R)-hydroxy Prostaglandin B2 (5 mg)    19(R)-OH PGB2, 19-R)-hydroxy Prostaglandin B2, 9-oxo-15S,19R-dihydroxy-prosta-5Z,8(12),13E-trien-1-oic acid
EAM2201 (1 mg)    JWH 21 N-(5-fluoropentyl) analog, EAM2201, (4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone
EAM2201 (5 mg)    JWH 21 N-(5-fluoropentyl) analog, EAM2201, (4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone
Metformin (1 g)    Biguanide|Cidophage|DMGG|Glucofine, Metformin, N,N-dimethyl-imidodicarbonimidic diamide
Metformin (10 g)    Biguanide|Cidophage|DMGG|Glucofine, Metformin, N,N-dimethyl-imidodicarbonimidic diamide
Metformin (5 g)    Biguanide|Cidophage|DMGG|Glucofine, Metformin, N,N-dimethyl-imidodicarbonimidic diamide
-+)-Methylenedioxy Pyrovalerone (1 mg)    (+)-MDPV, -+)-Methylenedioxy Pyrovalerone, 1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
-+)-Methylenedioxy Pyrovalerone (10 mg)    (+)-MDPV, -+)-Methylenedioxy Pyrovalerone, 1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
-+)-Methylenedioxy Pyrovalerone (5 mg)    (+)-MDPV, -+)-Methylenedioxy Pyrovalerone, 1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
--)-Methylenedioxy Pyrovalerone (1 mg)    (-)-MDPV, --)-Methylenedioxy Pyrovalerone, 1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
--)-Methylenedioxy Pyrovalerone (10 mg)    (-)-MDPV, --)-Methylenedioxy Pyrovalerone, 1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
--)-Methylenedioxy Pyrovalerone (5 mg)    (-)-MDPV, --)-Methylenedioxy Pyrovalerone, 1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
BW 245C (50 mg)    BW 245C, (4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid
BW 246C (50 mg)    8-epi BW 245C, BW 246C, (4R)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid
BW A868C (50 mg)    BW A868C, 3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxo-1-(phenylmethyl)-4-imidazolidineheptanoic acid